Impact of metabolic syndrome on specifics of hemodynamics and lipid profile in patients after percutaneous coronary interventions in acute myocardial infarction

Khokhlunov S.M.

Samarskiĭ oblastnoĭ klinicheskiĭ kardiologicheskiĭ dispanser

Kachkovskiĭ M.A.

GBOU VPO "Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii

Kuz'mina T.M.

GBOU VPO "Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii

Impact of metabolic syndrome on specifics of hemodynamics and lipid profile in patients after percutaneous coronary interventions in acute myocardial infarction

Authors:

Khokhlunov S.M., Kachkovskiĭ M.A., Kuz'mina T.M.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(2): 30‑33

Downloaded: 9

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Khokhlunov SM, Kachkovskiĭ MA, Kuz'mina TM. Impact of metabolic syndrome on specifics of hemodynamics and lipid profile in patients after percutaneous coronary interventions in acute myocardial infarction. Russian Journal of Cardiology and Cardiovascular Surgery. 2013;6(2):30‑33. (In Russ.)

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)

Close metadata

Systolic and diastolic left ventricular function and lipid profile were evaluated in patients after coronary stenting in acute myocardial infarction. 85 patients (72 men and 13 women) aged 43-72 years were investigated, including 42 people with metabolic syndrome and 43 people without one. It is shown that severity of dyslipidemia and degree of coronary affection are closely related to metabolic syndrome indicating the necessity of revascularization in acute myocardial infarction. Patients with metabolic syndrome present with more evident morphological changes of left ventricle and reduction of systolic and diastolic function. It is drawn a conclusion that patients with metabolic syndrome require complex therapeutic and surgical treatment with individual correction of risk factors.

Keywords:

coronary heart disease

myocardial infarction

revascularization

metabolic syndrome

dyslipidemia

ischemic dysfunction of left ventricle

Authors:

Khokhlunov S.M.

Samarskiĭ oblastnoĭ klinicheskiĭ kardiologicheskiĭ dispanser

Kachkovskiĭ M.A.

GBOU VPO "Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii

Kuz'mina T.M.

GBOU VPO "Samarskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii

List of references:

Aronov D.M., Lupanov V.P. Issledovanie COURAGE: obeskurazhivayut ili vpechatlyayut ego rezul'taty. Kardiovask ter i prof 2007; 6: 95-104.
Batyraliev T.A., Fettser D.V., Preobrazhenskii D.V. i dr. Optimal'nyi metod revaskulyarizatsii u bol'nykh s mnogososudistym porazheniem koronarnykh arterii pri primenenii stentov, vydelyayushchikh lekarstva: chreskozhnye koronarnye vmeshatel'stva, po sravneniyu s koronarnym shuntirovaniem. Kardiologiya 2010; 2: 84-90.
Belenkov Yu.N., Samkov A.N., Batyraliev T.A., Pershukov I.V. Koronarnaya angioplastika: vzglyad cherez 30 let. Kardiologiya 2007; 9: 4-14.
Bokeriya L.A., Kakitelashvili M.A., Sigaev I.Yu. Vliyanie ozhireniya na rezul'taty endovaskulyarnogo i khirurgicheskogo lecheniya ishemicheskoi bolezni serdtsa. Grudnaya i serdechno-sosud khir 2008; 8: 52-55.
Diagnostika i lechenie arterial'noi gipertenzii. Rekomendatsii Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii i Vserossiiskogo nauchnogo obshchestva kardiologov. Tretii peresmotr. Kardiovask ter i prof 2008; 2: 7 (prilozhenie).
Mamedov M.N. Metabolicheskii sindrom - bol'she chem sochetanie faktorov riska: printsipy diagnostiki i lecheniya. M: Vervag Farma 2006; 42.
Mychka V.B. Sovremennye predstavleniya o diagnostike i lechenii metabolicheskogo sindroma. Med aspekty zdorov'ya zhenshchiny 2008; 2 : 11; hmp.//woman.health-un.com/article/140 html.
Rekomendatsii ekspertov Vserossiiskogo nauchnogo obshchestva kardiologov po diagnostike i lecheniyu metabolicheskogo sindroma (vtoroi peresmotr). M 2009; 28.
Fettser D.V., Batyraliev T.A., Sidorenko B.A. i dr. Neposredstvennye i otdalennye rezul'taty chreskozhnykh koronarnykh vmeshatel'stv na "nezashchishchennom" stvole levoi koronarnoi arterii u bol'nykh vysokogo khirurgicheskogo riska. Vserossiiskii s''ezd serdechno-sosudistykh khirurgov, 14-i: Materialy. M 1992.
Boden W.E., O,Rourke R.A., Teo K.K. et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 15: 1503-1516.
Celik T., Turhan H., Kursaklioglu H. et al. Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction. Coron Artery Dis 2006; 17: 4: 339-343.
Gruberg L., Mercado N., Milo S. et al. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: The obesity paradox II? Am J Cardiol 2005; 95: 4: 439-444.
Hoffmann R., Stellbrink E., Schröder J. et al. Impact of the Metabolic Syndrome on Angiographic and Clinical Events After Coronary Intervention Using Bare-Metal or Sirolimus-Eluting Stents. Am J Cardiol 2007; 100: 9: 1347-1352.
Khattab A.A., Daemen J., Richardt G., et al. Impact of Body Mass Index on the One-Year Clinical Outcome of Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents (from the Arterial Revascularization Therapies Study Part II). Am J Cardiol 2008; 101: 11: 1550-1559.
Kuchulakanti P.K., Torguson R., Canos D.et al. Impact of Treatment of Coronary Artery Disease With Sirolimus-Eluting Stents on Outcomes of Diabetic and Nondiabetic Patients. Am J Cardiol 2005; 96 (8): 1100-1106.
Lindstrom J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
Mehta L., Devlin W., McCullough P.A. et al. Impact of Body Mass Index on Outcomes After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. Am J Cardiol 2007; 99: 7: 906-910.
Nikolsky E., Kosinski E., Mishkel G.J. et al. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol 2005; 95: 6: 709-715.
Sarno G., Garg S., Onuma Y., Buszman P. et al. The Impact of Body Mass Index on the One Year Outcomes of Patients Treated by Percutaneous Coronary Intervention With Biolimus- and Sirolimus-Eluting Stents (from the LEADERS Trial). Am J Cardiol 2010; 105 (4): 475-479.
Tahara S., Guagliumi G., Bezerra H.G. et al. Delayed Strut Coverage in a Diabetic Population Treated With Paclitaxel Eluting and Bare Metal Stents: Sub-analysis of the Horizons-OCT Trial. Circulation 2009; 120: S947.

Close metadata